Carregant...
SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir
December 2019 saw the emergence of a new epidemic of pneumonia of varying severity, called COVID-19, caused by a newly identified coronavirus, SARS-CoV-2. No therapeutic option is available to treat this infection that has already killed more than 235,000 people worldwide. This Viewpoint summarizes...
Guardat en:
| Publicat a: | Clin Infect Dis |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239253/ https://ncbi.nlm.nih.gov/pubmed/32409832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa587 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|